82 related articles for article (PubMed ID: 6468181)
1. Cytophotometrical and biochemical characterization of nonpalpable, mammographically detected mammary adenocarcinomas.
Fallenius AG; Skoog LK; Svane GE; Auer GU
Cytometry; 1984 Jul; 5(4):426-9. PubMed ID: 6468181
[TBL] [Abstract][Full Text] [Related]
2. Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas.
Azavedo E; Fallenius A; Svane G; Auer G
Am J Clin Oncol; 1990 Feb; 13(1):23-7. PubMed ID: 2154920
[TBL] [Abstract][Full Text] [Related]
3. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
4. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
[TBL] [Abstract][Full Text] [Related]
5. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
Tafra L; Essner R; Brenner RJ; Giuliano AE
Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
[TBL] [Abstract][Full Text] [Related]
6. Mammographically detected carcinoma of the breast.
Bauer TL; Pandelidis SM; Rhoads JE; Owens RS
Surg Gynecol Obstet; 1991 Dec; 173(6):482-6. PubMed ID: 1948608
[TBL] [Abstract][Full Text] [Related]
7. Non-palpable invasive breast carcinomas from the Stockholm screening project.
von Rosen A; Frisell J; Glas U; Hellström L; Nilsson R; Skoog L; Auer G
Acta Oncol; 1989; 28(1):23-7. PubMed ID: 2706131
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA analysis of invasive carcinomas detected by screening mammography: use of specimen mammography-guided fine-needle aspirates.
Stomper PC; DeBloom JR; Levine E; Budnick RM; Stewart CC
Clin Cancer Res; 1998 Jul; 4(7):1789-95. PubMed ID: 9676857
[TBL] [Abstract][Full Text] [Related]
9. Receptors for estrogen and progesterone in breast carcinoma in situ.
Pallis L; Wilking N; Cedermark B; Rutqvist LE; Skoog L
Anticancer Res; 1992; 12(6B):2113-5. PubMed ID: 1295456
[TBL] [Abstract][Full Text] [Related]
10. Ability of mammography to reveal nonpalpable breast cancer in women with palpable breast masses.
Rosen EL; Sickles E; Keating D
AJR Am J Roentgenol; 1999 Feb; 172(2):309-12. PubMed ID: 9930773
[TBL] [Abstract][Full Text] [Related]
11. [Study of DNA content using a flow cytometry method and steroid hormone receptors in breast cancer].
Zubrikhina GN; Kuz'mina EV; Bassalyk LS; Murav'eva NI
Vopr Onkol; 1989; 35(10):1179-86. PubMed ID: 2596061
[TBL] [Abstract][Full Text] [Related]
12. A comparison of palpable and nonpalpable breast cancers.
Pagana TJ; Lubbe WJ; Schwartz SM; Sprechini GD
Arch Surg; 1989 Jan; 124(1):26-8. PubMed ID: 2910245
[TBL] [Abstract][Full Text] [Related]
13. Pathological and biological features of mammographically detected invasive breast carcinomas.
Rajakariar R; Walker RA
Br J Cancer; 1995 Jan; 71(1):150-4. PubMed ID: 7819032
[TBL] [Abstract][Full Text] [Related]
14. Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas.
Skandalis SS; Labropoulou VT; Ravazoula P; Likaki-Karatza E; Dobra K; Kalofonos HP; Karamanos NK; Theocharis AD
BMC Cancer; 2011 Jul; 11():314. PubMed ID: 21791066
[TBL] [Abstract][Full Text] [Related]
15. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
16. Results from a multidisciplinary breast center. Analysis of disease discovered.
Silverstein MJ; Gamagami P; Masetti R; Legmann MD; Craig PH; Gierson ED
Surg Oncol Clin N Am; 1997 Apr; 6(2):301-14. PubMed ID: 9115497
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years.
Osako T; Iwase T; Takahashi K; Iijima K; Miyagi Y; Nishimura S; Tada K; Makita M; Akiyama F; Sakamoto G; Kasumi F
Breast Cancer; 2007; 14(3):255-9. PubMed ID: 17690501
[TBL] [Abstract][Full Text] [Related]
19. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
20. Steroid-hormone receptors in nonpalpable and more advanced stages of breast cancer. A contribution to the biology and natural history of carcinoma of the female breast.
Tinnemans JG; Beex LV; Wobbes T; Sluis RF; Raemaekers JM; Benraad T
Cancer; 1990 Sep; 66(6):1165-7. PubMed ID: 2400967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
